As of 2025-09-18, the Relative Valuation of Oncolytics Biotech Inc (ONC.TO) is (0.03) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.42 CAD, the upside of Oncolytics Biotech Inc based on Relative Valuation is -102.4%.
The range of the Relative Valuation is (0.03) - (0.07) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 0.2x | 0.1x |
| Forward P/E multiples | 0.1x - 0.2x | 0.1x |
| Fair Price | (0.03) - (0.07) | (0.03) |
| Upside | -101.9% - -104.8% | -102.4% |
| Date | P/E |
| 2025-08-22 | -4.15 |
| 2025-08-21 | -4.06 |
| 2025-08-20 | -4.09 |
| 2025-08-19 | -4.00 |
| 2025-08-18 | -4.15 |
| 2025-08-15 | -4.35 |
| 2025-08-14 | -3.91 |
| 2025-08-13 | -4.09 |
| 2025-08-12 | -3.42 |
| 2025-08-11 | -3.45 |
| 2025-08-08 | -3.45 |
| 2025-08-07 | -3.68 |
| 2025-08-06 | -3.80 |
| 2025-08-05 | -3.86 |
| 2025-08-01 | -4.00 |
| 2025-07-31 | -4.09 |
| 2025-07-30 | -4.21 |
| 2025-07-29 | -4.15 |
| 2025-07-28 | -4.41 |
| 2025-07-25 | -4.23 |
| 2025-07-24 | -4.47 |
| 2025-07-23 | -4.70 |
| 2025-07-22 | -4.88 |
| 2025-07-21 | -4.82 |
| 2025-07-18 | -5.05 |
| 2025-07-17 | -5.20 |
| 2025-07-16 | -4.96 |
| 2025-07-15 | -4.47 |
| 2025-07-14 | -4.73 |
| 2025-07-11 | -4.67 |
| 2025-07-10 | -4.41 |
| 2025-07-09 | -4.70 |
| 2025-07-08 | -4.96 |
| 2025-07-07 | -4.00 |
| 2025-07-04 | -3.36 |
| 2025-07-03 | -3.62 |
| 2025-07-02 | -3.07 |
| 2025-06-30 | -3.04 |
| 2025-06-27 | -3.04 |
| 2025-06-26 | -2.86 |
| 2025-06-25 | -2.72 |
| 2025-06-24 | -2.72 |
| 2025-06-23 | -2.51 |
| 2025-06-20 | -2.80 |
| 2025-06-19 | -2.83 |
| 2025-06-18 | -2.95 |
| 2025-06-17 | -2.60 |
| 2025-06-16 | -2.54 |
| 2025-06-13 | -2.39 |